Literature DB >> 2295179

Exposed endoprosthesis. Management protocol using muscle and myocutaneous flap coverage.

J J Eckardt1, M A Lesavoy, T J Dubrow, P A Wackym.   

Abstract

A tenet in the orthopedic community is that dehiscent wounds overlying exposed prostheses should be treated by implant removal and delayed reconstruction. A management protocol using thorough debridement and irrigation and muscle flap coverage was accomplished in four patients with exposed endoprostheses after total arthroplasty or limb salvage surgery. Predisposing factors for late wound dehiscence in the four oncology patients were preoperative radiation and chemotherapy as well as multiple subsequent reoperations. In this study, all four prostheses and extremities were retained without the need for prosthetic removal or exchange. No infections developed. Late aseptic wound dehiscence with exposed conventional or tumor endoprosthesis need not be managed with prosthetic removal, arthrodesis, or amputation. This one-stage procedure avoided infection, allowed early mobilization, shortened hospitalization and, most important, avoided amputations.

Entities:  

Mesh:

Year:  1990        PMID: 2295179

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  4 in total

Review 1.  [Literature and own strategies concerning soft-tissue reconstruction and exposed osteosynthetic hardware].

Authors:  S Baumeister; L S Levin; D Erdmann
Journal:  Chirurg       Date:  2006-07       Impact factor: 0.955

2.  Infection in limb salvage surgery for bone tumors.

Authors:  D Donati; R D'Arenzo; C Ercolani; S Boriani
Journal:  Eur J Orthop Surg Traumatol       Date:  1995-12

3.  Role of staged endoprosthetic revision with flap cover for limb salvage in endoprosthetic failure.

Authors:  Krishna Rao; Anindya Lahiri; Francis C Peart
Journal:  Int Orthop       Date:  2006-04-11       Impact factor: 3.075

4.  Cemented distal femoral endoprostheses for musculoskeletal tumor: improved survival of modular versus custom implants.

Authors:  Adam J Schwartz; J Michael Kabo; Fritz C Eilber; Frederick R Eilber; Jeffrey J Eckardt
Journal:  Clin Orthop Relat Res       Date:  2009-12-22       Impact factor: 4.176

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.